10:30 - 11:45 | Digital Technologies | Hall 6a |
10:30 - 11:45 | EP Masterclass 1 | Hall 11a |
10:30 - 11:45 | Oral Abstracts 1 | Hall 11b |
10:30 - 11:45 | Arrhythmogenic Cardiomyopathy: Updates and Best Practice | Executive Room 1 |
11:30 - 18:45 | EP Traces Course | Hall 7b |
12:15 - 13:30 | Arrhythmia Alliance Symposia 1 - Everything you wanted to know about Pulsed Field Ablation | Hall 11b |
12:15 - 13:30 | Masterclass Devices 1 -Tricuspid regurgitation and CIEDs – Optimal management strategies | Hall 11a |
12:15 - 13:30 | Oral Abstracts 1 | Hall 11b |
14:45 - 16:15 | Conduction System Pacing 1 | Hall 6a |
14:45 - 16:00 | Rhythm control should be considered first line in all patients with AF? | Hall 11a |
14:45 - 16:15 | Arrhythmia Alliance Symposia 2 - Focus on Conduction System Pacing | Hall 11b |
14:45 - 16:15 | Basic Science Primer | Executive Room 1 |
16:45 - 18:15 | Year in Review 1 - AF what's new in 2024? | Hall 6a |
16:45 - 18:15 | AF Association Symposia 1 - Catheter Ablation in 2024: State of the Art | Hall 11a |
Chair: Dr Fu Siong Ng, Dr Mark Tanner | London, UK, Chichester, UK | |||
---|---|---|---|---|
10:30 | Direct to Consumer Wearables: Can we trust the data? | Dr Ahran Arnold | London, UK | |
10:45 | Insights and Highlights from the `EHRA Digital Devices Practical Guide | |||
11:00 | AI in a Nutshell: Current Applications in Arrhythmia Management | Prof Sanjiv Narayan | Palo Alto, US | |
11:15 | Future Horizons in AI; Prognostic, Therapeutic, and Superhuman Diagnostics | Dr Arunashis Sau | London, UK | |
11:30 | Final discussions | |||
11:45 | Close |
Chair: Dr Manish Kalla | Birmingham, UK | |||
---|---|---|---|---|
10:30 | Insights from PFA: is it more than park it by a vein and press ‘GO' | |||
10:45 | When is moderate mitral regurgitation a reason to not offer AF ablation? | Dr Manav Sohal | London, UK | |
11:00 | Is there space in the real world for ‘personalised ablation’ in persistent AF? | Dr Matt Wright | London, UK | |
11:15 | Ablation for all severe heart failure patients with AF after CASTLE-HTX? | |||
11:30 | Final discussions | |||
11:45 | Close |
Chair: | ||||
---|---|---|---|---|
Further details coming soon | ||||
11:45 | Close |
Chair: Dr John Whitaker, Dr Stephen Page | London, UK, Leeds, UK | |||
---|---|---|---|---|
10:30 | Arrhythmogenic cardiomyopathy - definitions and diagnostic criteria | Prof Juan Pablo Kaski | London, UK | |
10:45 | The genetics of arrhythmogenic cardiomyopathy | |||
11:00 | Assessing and managing risk in arrhythmogenic cardiomyopathy | |||
11:15 | How to perform catheter ablation in patients with arrhythmogenic cardiomyopathy | |||
11:30 | Panel discussion | |||
11:45 | Close |
Chair: | ||||
---|---|---|---|---|
11:30 | Welcome, course objectives and ‘How to approach the unknown tracing’ | |||
11:45 | EP traces session 1 - 4 (please note there will be lunch, followed by 2 x breaks throughout the day) | |||
18:45 | Close |
Chair: Dr David Jones | Uxbridge, UK | |||
---|---|---|---|---|
12:15 | General anaesthesia or conscious sedation for PFA - is the jury still out? | Prof Julian Chun | Frankfurt, DE | |
12:25 | What should I know about the different PFA electrical waveforms and their effects? | |||
12:35 | Are contact force and lesion assessment algorithms relevant in PFA? | Prof Nico Reinsch | Essen, DE | |
12:45 | What are the potential complications with PFA we should be cautious about? | |||
12:55 | What's on the horizon for PFA technology? | |||
13:05 | Q&A | |||
13:30 | Close |
Chair: Dr Peysh Patel | Birmingham, UK | |||
---|---|---|---|---|
12:15 |
Size of problem/predictors of the problem - Overview – how often is it a reality |
|||
12:40 | Multimodality imaging and Assessment of TR | |||
13:05 | Management of TR in the device patient | |||
13:30 | Close |
Chair: | ||||
---|---|---|---|---|
Further details coming soon | ||||
13:30 | Close |
Chair: Dr Antony French, Dr Mokhtar Ibrahim | Hereford, UK, Leicester, UK | |||
---|---|---|---|---|
Will CSP replace conventional CRT? | ||||
14:45 | Pro | |||
15:05 | Con | Prof Francisco Leyva | Birmingham, UK | |
Will CSP replace conventional RV pacing? | ||||
15:25 | Pro | Dr Badrinathan Chandrasekaran | Swindon, UK | |
15:45 | Con | Dr Ian Loke | Leicester, UK | |
16:05 | Q&A | |||
16:15 | Close |
Chair: | ||||
---|---|---|---|---|
14:45 | Pro | |||
15:15 | Con | Dr Christian Camm | Reading, UK | |
15:45 | Final discussions | |||
16:00 | Close |
Chair: Dr Zachary Whinnett | London, UK | |||
---|---|---|---|---|
14:45 | CSP for bradycardia pacing: summary of evidence | |||
15:00 | When should I consider CSP for CRT and what approach should I use? | Dr Nadine Ali | London, UK | |
15:15 | Delivering CSP in clinical practice: overview of guidelines and consensus documents | |||
15:30 | Does it matter which part of the conduction system we capture? | Dr Karol Curila | Prague, CZ | |
15:45 | How to confirm conduction system capture: insights from invasive mapping studies | Dr Ahran Arnold | London, UK | |
16:00 | Panel discussion | |||
16:15 | Close |
Chair: Dr Fu Siong Ng | London, UK | |||
---|---|---|---|---|
14:45 | Conduction system dysfunction in athletes | Dr Alicia D'Souza | London, UK | |
15:05 | In silico trials for drug development | Prof Blanca Rodriguez | Oxford, UK | |
15:25 | AI-enabled electrocardiogram for risk prediction | Dr Fu Siong Ng | London, UK | |
15:45 | Action potential (and T wave) alternans and arrhythmias | |||
16:05 | Final discussions | |||
16:15 | Close |
Chair: | ||||
---|---|---|---|---|
16:45 |
Anticoagulation - Current and future developments / top 10 messages from ESC guidelines |
|||
17:15 | Percutaneous / surgical approaches to stroke reduction | |||
17:45 |
Ablation techniques - QDOT/PFA - Safety/efficacy - Anything other than the veins? 1 size fits all vs personalized approach for all |
|||
18:15 | Close |
Chair: | ||||
---|---|---|---|---|
16:45 | Catheter ablation of AF Then and Now: A Historical Perspective | |||
16:55 | Techniques and Outcomes of Thermal AF Ablation in 2024 | Dr David Jones | Uxbridge, UK | |
17:05 | Persistent atrial fibrillation ablation: from endocardial to epicardial | |||
17:15 | Electroporation: A State-of-the-Art Review | |||
17:25 | First Line AF Ablation | |||
17:35 | AF Ablation: Predictions for the future | Dr Matt Wright | London, UK | |
17:45 | Q&A | |||
18:15 | Close |